Company · CIK 0001384101 · SIC 8071 — Services-Medical Laboratories · Nasdaq
VERACYTE, INC. · VCYT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 SForm 4 → | Sep 22, 5:16 pm EDT | John LeiteGlobal Chief Commercial Off | 4,015 | $40.00 | $160,600 | 124,329 | −3.13% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 16, 4:08 pm EDT | Jens HolsteinDirector | 5,000 | $40.95 | $204,747 | 27,471 | −15.4% | 10b5-1 |
| Sep 4, 2026 SForm 4 → | Sep 4, 7:54 pm EDT | Phillip G. FebboChief Scientific & Med Officer | 13,110 | $43.05 | $564,410 | 133,048 | −8.97% | 10b5-1 |
| Sep 4, 2026 SForm 4 → | Sep 4, 7:54 pm EDT | Rebecca ChambersChief Financial Officer | 3,652 | $43.10 | $157,394 | 166,025 | −2.15% | 10b5-1 |
| Sep 4, 2026 SForm 4 → | Sep 4, 7:54 pm EDT | Annie McGuireEVP, General Counsel | 3,254 | $43.09 | $140,212 | 131,160 | −2.42% | 10b5-1 |
| Sep 2, 2026 FForm 4 → | Sep 4, 7:54 pm EDT | Jonathan WygantVP, Chief Accounting Officer | 1,361 | $44.88 | $61,082 | 43,226 | — | |
| Sep 2, 2026 FForm 4 → | Sep 4, 7:54 pm EDT | John LeiteGlobal Chief Commercial Off | 3,961 | $44.88 | $177,770 | 128,344 | — | |
| Sep 2, 2026 FForm 4 → | Sep 4, 7:54 pm EDT | Phillip G. FebboChief Scientific & Med Officer | 3,639 | $44.88 | $163,318 | 146,158 | — | 10b5-1 |
| Sep 2, 2026 FForm 4 → | Sep 4, 7:54 pm EDT | Rebecca ChambersChief Financial Officer | 3,603 | $44.88 | $161,703 | 169,677 | — | 10b5-1 |
| Sep 2, 2026 FForm 4 → | Sep 4, 7:54 pm EDT | Annie McGuireEVP, General Counsel | 3,215 | $44.88 | $144,289 | 134,414 | — | 10b5-1 |
| Sep 2, 2026 FForm 4 → | Sep 4, 7:53 pm EDT | Marc StapleyChief Executive Officer, Director | 8,782 | $44.88 | $394,136 | 432,073 | — | |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:48 pm EDT | Muna BhanjiDirector | 1,864 | $42.97 | $80,096 | 42,718 | −4.18% | 10b5-1 |
| Jun 18, 2026 SForm 4 → | Jun 22, 4:30 pm EDT | Karin EasthamDirector | 3,729 | $52.89 | $197,234 | 15,097 | −19.8% | 10b5-1 |
| Jun 11, 2026 AForm 4 → | Jun 15, 4:56 pm EDT | Karin EasthamDirector | 5,272 | — | — | 18,826 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 4:56 pm EDT | Evan/ Fa JonesDirector | 5,272 | — | — | 34,634 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 4:56 pm EDT | David Brent ShaferDirector | 5,272 | — | — | 31,100 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 4:56 pm EDT | Eliav BarrDirector | 5,272 | — | — | 56,461 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 4:55 pm EDT | Robert S EpsteinDirector | 5,272 | — | — | 57,718 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 4:55 pm EDT | Jens HolsteinDirector | 5,272 | — | — | 32,471 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 4:55 pm EDT | Muna BhanjiDirector | 5,272 | — | — | 44,582 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 4:55 pm EDT | Thomas F. MillerDirector | 5,272 | — | — | 31,100 | — | |
| Jun 4, 2026 SForm 4 → | Jun 4, 9:38 pm EDT | Annie McGuireEVP, General Counsel | 3,176 | $49.76 | $158,036 | 137,240 | −2.26% | 10b5-1 |
| Jun 4, 2026 SForm 4 → | Jun 4, 9:38 pm EDT | Rebecca ChambersChief Financial Officer | 3,561 | $49.73 | $177,083 | 173,280 | −2.01% | 10b5-1 |
| Jun 4, 2026 SForm 4 → | Jun 4, 9:38 pm EDT | Marc StapleyChief Executive Officer, Director | 138,051 | $50.12 | $6,919,585 | 440,494 | −23.9% | 10b5-1 |
| Jun 4, 2026 SForm 4 → | Jun 4, 9:38 pm EDT | John LeiteGlobal Chief Commercial Off | 13,975 | $50.07 | $699,732 | 132,305 | −9.55% | 10b5-1 |
| Jun 2, 2026 FForm 4 → | Jun 4, 9:38 pm EDT | Annie McGuireEVP, General Counsel | 3,292 | $47.80 | $157,358 | 140,416 | — | 10b5-1 |
| Jun 2, 2026 FForm 4 → | Jun 4, 9:38 pm EDT | Jonathan WygantVP, Chief Accounting Officer | 1,361 | $47.80 | $65,056 | 44,073 | — | |
| Jun 2, 2026 FForm 4 → | Jun 4, 9:38 pm EDT | Rebecca ChambersChief Financial Officer | 3,693 | $47.80 | $176,525 | 176,841 | — | 10b5-1 |
| Jun 2, 2026 FForm 4 → | Jun 4, 9:38 pm EDT | Phillip G. FebboChief Scientific & Med Officer | 3,730 | $47.80 | $178,294 | 149,797 | — | 10b5-1 |
| Jun 2, 2026 FMForm 4 → | Jun 4, 9:38 pm EDT | Marc StapleyChief Executive Officer, Director | 147,063 | $37.29 | $5,483,440 | 578,545 | — | 10b5-1 |
| Jun 2, 2026 FForm 4 → | Jun 4, 9:38 pm EDT | John LeiteGlobal Chief Commercial Off | 4,059 | $47.80 | $194,020 | 146,280 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 MForm 4 → | Jun 4, 9:38 pm EDT | Marc StapleyChief Executive Officer, Director | 138,051 | — | — | 0 | — | 10b5-1 |